NCT06723665View on ClinicalTrials.gov

The Exploration of 18F-PSMA-1007 PET/CT Imaging in Prostate Cancer Patients

NAEnrolling by invitationINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 25, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Prostate Cancer
Interventions
DRUG

18F-PSMA-1007

18F-PSMA-1007 is administered through a superficial dorsal vein, and the patient is given a dose of about 0.1-0.15mCi/kg

DRUG

18F-FDG

18F-FDG is administered through a superficial dorsal vein, and the patient is given a dose of about 0.1-0.15mCi/kg

Trial Locations (1)

214000

Affiated Hospital of Jiangnan University, Wuxi

All Listed Sponsors
lead

Affiliated Hospital of Jiangnan University

OTHER